The Institute for Patient Access (IFPA) review of Medicare data for patients with rheumatoid arthritis (RA), Crohn’s disease or immunodeficiency found that concerns about the negative consequences of non-medical switching are warranted. Specifically, they concluded that non-medical switching can negatively impact patient care and increase healthcare expenses, particularly for RA patients. Read more.
A change of medication in a stable patient for non-medical reasons puts the patient at unnecessary risk, according to the Coalition of State Rheumatology Organizations (CSR0). Absent any medical reason for the switch, the CSRO says patients should be allowed to remain on their current medication as long as they are medically stable. Read more.
Global Healthy Living Foundation 50-State Network advocate Lisa Tent delivers Osteoporosis patient perspective to ICER, the Institute for Clinical and Economic Review.
Conclusions from the Institute for Clinical and Economic Review’s forthcoming draft on osteoporosis treatments anti-patient and methodologically flawed.
Global Healthy Living Foundation President and Co-Founder, Seth Ginsberg, issued a powerful statement to Iowa Governor Terry Branstad urging him to support House Bill 233.